MP Materials (MP) — Q2 FY2026 Earnings Briefing

Fiscal period: Q2 FY2026 (quarter ended June 30, 2026) · Report date: September 19, 2026 (prepared from the Q2 2026 earnings call transcript)


Executive Summary

  • Revenue more than doubled year over year: $126.1 million of revenue plus PPA income, driven primarily by a 127% YoY increase in NdPr sales volumes. Consolidated adjusted EBITDA was $28.5 million, a $41 million YoY improvement; adjusted diluted EPS improved $0.12 YoY to a loss of $0.01.
  • Materials segment strength: $113.2 million of revenue plus PPA income and $32.5 million of adjusted EBITDA — a $45 million YoY improvement — even though NdPr production of 840 metric tons (+41% YoY) was achieved through an extended planned April plant shutdown.
  • Sales continue to outrun production: NdPr sales exceeded 1,000 metric tons for the second consecutive quarter while production was 840 tons; ~650 tons of NdPr oxide and metal were on hand, in transit, or awaiting shipment at June 30. Q3 production is guided above 1,000 metric tons with significant volume growth expected next quarter toward the targeted year-end run rate.
  • Three growth initiatives advancing in parallel: the heavy rare earth (Dy/Tb) separation circuit reached mechanical completion in May with feed introduction “imminent” and terbium/dysprosium production on track later this year; the on-site chlor-alkali restart hit milestones (additional brine pre-treatment online, improving crystallizer performance); and ground-breaking this month on an expanded area housing magnet recycling plus additional heavy rare earth separation and finishing.
  • First heavy rare earth commercial win: a July long-term agreement to supply gadolinium oxide to a leading U.S. aerospace and defense manufacturer — a sizable 9-figure deal over multiple years with locked-in economics, framed as the first of many possible heavies monetizations.
  • Magnetics on the cusp of commercial revenue: magnets were delivered to GM for in-vehicle qualification testing; commercial shipments remain on track to begin in Q4 2026 with a steady ramp thereafter. Precursor production delivered adjusted EBITDA margins exceeding 40%. Approximately $46 million of prepaid precursor revenue remains to be recognized over the next 3–4 quarters on a modestly declining basis.
  • 10X is now vertical: foundation work underway, long-lead equipment ordered, and — announced live on the call — the company is “officially vertical” on the 10X site acquired for ~$80 million this quarter. Independence is substantially committed (GM, Apple) and 10X is 100% contracted with the Department of War (DOW).
  • Balance sheet funds the build: $1.45 billion of cash and short-term investments; Q2 CapEx of $230.3 million (>60% Magnetics, including the ~$80M 10X site), $308 million year to date, and full-year CapEx guided to $500–600 million.

Highlights and Lowlights

Highlights

  • Materials earnings power inflecting: segment adjusted EBITDA of $32.5M, a $45M YoY swing; consolidated adjusted EBITDA of $28.5M (+$41M YoY); revenue plus PPA income of $126.1M, more than doubling YoY.
  • Volume growth on track: 840 mt NdPr produced (+41% YoY, in line with expectations despite the extended April shutdown); Q3 production guided >1,000 mt; “significant volume growth next quarter” toward the year-end run-rate target.
  • Demand exceeds supply: NdPr sales >1,000 mt for a second straight quarter (+127% YoY); management repeatedly stated customer demand “continues to outpace our production growth.”
  • Gadolinium offtake: 9-figure, multi-year, locked-in-economics agreement with a leading U.S. aerospace and defense manufacturer; attractive standalone returns with volume growth available “at significant incremental return given the vast majority of the capital being deployed upfront.”
  • Heavy rare earth circuit nearly live: mechanical completion achieved in May; punch-list, equipment checkouts, and initial commissioning done; feed introduction imminent; Dy/Tb production and first Mountain Pass-to-Independence shipments on track for later this year.
  • GM qualification milestone cleared: magnets delivered for in-vehicle testing; the team is “now demonstrating the capability and consistency required to support our customers’ volume ramp, clearing one of the most important milestones in the qualification process”; commercial deliveries begin Q4. Behind the scenes, MP had its best metal production quarter ever.
  • Magnetics precursor economics: adjusted EBITDA margins exceeding 40% on precursor production, “highlighting the earnings potential of the Magnetics segment.”
  • Portfolio breadth: samarium program on plan for first production in 2028 (per DOW commitments); gadolinium project moving to engineering/procurement on a similar timeline; yttrium identified as another monetization opportunity; exploratory drilling suggests potential additional ore within existing pit contours.
  • 10X momentum: site acquired (~$80M), foundation work underway, long-lead production equipment ordered, vertical construction confirmed live on the call; Independence learnings and customer feedback feeding final equipment selection.
  • Project Swarm launched: subscription agreements already signed with U.S. and allied drone manufacturers to aggregate and standardize future magnet demand — a demand-coordination mechanism ahead of capacity.
  • Resilient supply chain: full plant reagent trial with “very encouraging results” (change planned later this year, non-China supplier confirmed); chlor-alkali restart showing early crystallizer benefits; management expects minimal impact from China’s export-ban list on reagents/costs.

Lowlights

  • Sequential fade before the magnet inflection: consolidated adjusted EBITDA declined modestly q/q, reflecting the planned biannual plant shutdown and the Magnetics transition period ahead of commercial magnet revenue; Materials revenue plus PPA income was flat sequentially on identical sales volumes.
  • Q3 is guided soft: realized NdPr oxide pricing expected only in the high-$90s/kg with PPA income at roughly $10/kg versus market pricing hovering ~$110/kg early in Q3; minimal PPA income from stockpiled NdPr in concentrate; a slight sequential decline in overall PPA income; Materials sales volumes flattish depending on mix.
  • The production/sales gap cuts both ways: sales (1,000+ mt) again outpaced production (840 mt) — evidence of demand, but it draws down the ~650-ton finished-goods channel that management says must eventually be refilled as production scales.
  • Magnetics revenue declined sequentially: a much higher proportion of costs attributable to magnet start-up versus precursor production pressured metal product pricing ahead of commercial magnet sales; start-up overhead, labor, and materials costs are not yet inventoriable and hit the P&L directly.
  • Cost headwinds visible in the P&L: the April maintenance outage and staffing ahead of heavy rare earth production are “apparent in the P&L right now”; Dy/Tb costs will move into inventory and only be recognized through future magnet sales; the new reagent carries a “modestly higher” direct cost; broader cost improvement is deferred — benefits “build progressively through ‘27.”
  • EPS still negative: adjusted diluted EPS of -$0.01 despite the more-than-doubled revenue — a reminder that the ramp spend front-runs the revenue.
  • Heavy CapEx burn: $230.3M in the quarter, $308M YTD, $500–600M full-year — absorbed today only because of the $1.45B cash position.
  • Defense NdPr demand immaterial today: management sized current U.S. defense NdPr demand as “relatively immaterial” (e.g., drones: ~12M units/yr globally ≈ 500–1,000 tons of magnet demand, essentially 100% made in China today) — the payoff is framed 3–5 years out.
  • Scarcity cuts as risk as well as opportunity: Litinsky flagged “real disruption” in aerospace supply chains under China’s “controlled scarcity” regime — good for pricing, but a warning that the demand environment is volatile (he cited Honeywell Aerospace losing a quarter of its value over a small upstream supply shortfall).

1. The Quarter in Numbers

  • Consolidated: revenue plus PPA income of $126.1M (more than doubled YoY); adjusted EBITDA $28.5M (+$41M YoY); adjusted diluted EPS -$0.01 (+$0.12 YoY).
  • Materials: revenue plus PPA income $113.2M; adjusted EBITDA $32.5M (+$45M YoY). Sequentially flat revenue on identical sales volumes and the price-floor impact.
  • Magnetics: revenue declined slightly q/q as a higher proportion of costs was attributable to magnet start-up versus precursor production — which “impacts the pricing of our metal products ahead of commercial magnet production.” Precursor adjusted EBITDA margins exceeded 40%.
  • Production vs. sales: NdPr production 840 mt (+41% YoY); NdPr sales >1,000 mt (+127% YoY), second consecutive quarter above 1,000 tons.
  • Q3 outlook: high-$90s/kg realized NdPr pricing; ~$10/kg PPA income; ~$110/kg market pricing early in the quarter; flattish volumes; slight sequential decline in PPA income.
  • Cash and CapEx: $1.45B cash and short-term investments; Q2 CapEx $230.3M (>60% Magnetics; includes ~$80M 10X site acquisition); $308M YTD; FY guide $500–600M. Management: the balance sheet “fully funds our long-term capital plan.”

2. The Gadolinium Deal: A Template for Heavies Monetization

The July agreement — a 9-figure, multi-year gadolinium oxide supply deal with a leading U.S. aerospace and defense manufacturer — was the quarter’s headline commercial announcement, and management explained its logic as a deliberate sequencing play:

  • Where it came from: separating dysprosium and terbium first leaves an SEG (rare earth group) product stream; the gadolinium offtake is “a very logical way” to maximize its economics. MP had committed in its DOW agreements to begin samarium production in 2028; gadolinium engineering/procurement follows “a similar timeline” after an extended, technically successful pilot campaign.
  • Economics: “locked in” — no spot-price exposure — and “very attractive on a stand-alone basis,” with upside from follow-on volumes at significant incremental return since most capital is deployed upfront.
  • The doctrine: “We expand our product portfolio where customer demand and attractive returns justify investment, building the Materials segment one product at a time.” Samarium (2028) and yttrium were named as the next monetization candidates.
  • Why it matters beyond the P&L: Litinsky framed the deal as evidence of a regime of “controlled scarcity” — “no heavies getting out of China” and magnets on a licensing basis — with “real disruption” (not yet “full-on panic”) emerging in aerospace supply chains. He cited Honeywell Aerospace losing a quarter of its value on the day, which management tied to a small ($10–15M) upstream supply shortfall, as proof of how critical small-volume materials have become.

3. Operations: The Path to >1,000 Tons and Lower Costs

Michael Rosenthal’s operational review centered on throughput, cost, and the three upstream initiatives:

  • NdPr trajectory: Q3 production expected to exceed 1,000 metric tons; a handful of reliability-challenged circuits are being addressed with targeted equipment upgrades; plant reliability, throughput, and consistency “continue to trend in the right direction.”
  • Heavy rare earth circuit: mechanical completion in May; punch list, equipment checkouts, and initial commissioning complete; feed introduction imminent; Dy/Tb production later this year, prioritizing “quality over quantity” — with the ramp profile dependent on commissioning realities.
  • Chlor-alkali restart: additional brine pre-treatment brought online; early positive results in crystallizer performance; tangible cost benefits expected as part of a clear “path to lowering our cost structure,” building progressively through 2027 alongside fixed-cost absorption at target throughput.
  • Process innovation: a full-plant reagent trial (change later this year; modestly higher direct cost, better reclaimed-water quality, supply-chain resiliency, non-China source); pre-flotation piloting for scale implementation by 2028 to improve concentrate quality with midstream cost/uptime/quality benefits; exploratory drilling suggesting additional ore within existing pit contours.
  • Recycling ground-break: land cleared and demolition complete; ground-breaking this month on an expanded area housing both magnet recycling and additional heavy rare earth separation and finishing — reinforcing the vertical-integration thesis following the U.S. ban on magnet scrap exports.
  • Magnetics execution: scaling toward 24/7 production across all major processes; the auto-grade qualification rigor is positioned as a moat for future demanding customers; Apple collaboration (recycling, production, joint development) advancing; heavy rare earth intensity steadily being reduced via Grain Boundary Diffusion and process innovation, supported by a 100-plus engineer team.

4. Magnetics: The Lumpy Bridge to Commercial Revenue

Ryan Corbett was explicit that the coming quarters are transition quarters:

  • P&L mechanics: as magnet production facilities began trial shipments and run-rate testing, “a pretty significant amount of overhead and the labor and materials costs… are not yet inventoriable” and flow straight to expense. Precursor pricing structure forces cost reallocation from metal production into the magnet portion of the facility — one reason Magnetics revenue slipped q/q even as MP posted its best metal production quarter ever.
  • Prepaid runway: ~$46 million of prepaid precursor revenue to be recognized over the next 3–4 quarters, modestly declining q/q; once exhausted, external precursor sales end and metal capacity is dedicated to magnets.
  • Commercial milestone: magnets delivered to GM for in-vehicle qualification; commercial shipments begin Q4 2026 with modest volumes ramping over following quarters, sequenced against GM motor-plant demand. The 2027 cadence toward the initial 1,000-tons-per-year Independence nameplate will be detailed “as we get closer to the end of the year.”
  • Contracting posture: Independence is fully sold out between GM and Apple (with room for “another customer or 2”); 10X is 100% contracted with the Department of War, though management expects to contract “almost all” of that capacity to industry as the facility comes online. Management is explicitly patient: “we are in no rush to announce a deal to announce a deal.”

5. Demand Thesis: Physical AI and Controlled Scarcity

Litinsky closed with the macro thesis and leaned into it throughout the Q&A:

  • General-purpose technology framing: markets historically undervalue infrastructure phases; AI is approaching the transition “from creating intelligence to deploying it into the physical economy” — machines that “manufacture, move, build, transport, and defend.” Governments increasingly view that supply chain as a strategic capability — “a structural shift, not a cyclical one.”
  • The math that matters: at 30–40 million humanoid robots per year, robotics alone would consume 100% of global rare earth magnet production including China. Drone production (~12M units/yr) is ~500–1,000 tons of magnet demand — immaterial today, essentially 100% Chinese, but “quite large” in 3–5 years, with MP positioned as effectively the only non-China supplier for the U.S. defense supply chain.
  • Project Swarm: subscription agreements signed with drone manufacturers to standardize magnet grades around DOW-preferred specifications and aggregate demand that is individually immaterial — “we are capitalists, but we are first and foremost, patriots” — before the entire American drone industry’s magnet demand today is smaller than MP’s GM business alone.
  • NdPr as the binding constraint: management repeatedly asserted that NdPr — not magnets or heavies capacity — is the binding constraint for the foreseeable future, with a Micron-style demand squeeze possible as physical AI use cases come online.

Conclusion

This was a strong execution quarter with the financial inflection still ahead of it: Materials earnings power (+$45M YoY EBITDA), record metal production, and the gadolinium offtake validate the “one product at a time” compounding model, while the heavy rare earth circuit, chlor-alkali restart, and 10X vertical construction de-risk the next phase of the platform. The lowlights are mostly mechanical and telegraphed — negative EPS, sequentially softer EBITDA, flattish Q3 volumes with only ~$10/kg PPA income, and a Magnetics P&L that will stay lumpy until commercial magnet revenue begins in Q4 — and management was transparent about all of them. The investment case now hinges on two near-term proofs: first commercial magnet deliveries to GM in Q4 and NdPr production sustaining above 1,000 tons per quarter. If both land on schedule, the quarter’s forward-looking thesis — controlled scarcity, physical AI demand, and a fully funded build-out — has credible legs into 2027.


Artifacts and Follow-Ups

Key Artifacts — highest priority

  1. First commercial magnet deliveries to GM in Q4. This is the single event that flips the Magnetics segment from cost center to revenue generator and validates the qualification narrative (“extremely encouraging” results, capability/consistency milestone cleared). Baseline: management committed to commercial shipments beginning in Q4 2026 with modest volumes. Next print confirms/refutes whether deliveries started and the early ramp cadence.
  2. NdPr production exceeding 1,000 metric tons in Q3. Production of 840 mt (+41% YoY) must step up as guided; management committed to >1,000 mt in Q3 and “significant volume growth next quarter” toward the year-end run rate. Next print confirms/refutes the year-end run-rate trajectory and the fixed-cost absorption math behind the 2027 cost-down story.
  3. First Dy/Tb output and Mountain Pass-to-Independence shipments. The heavy rare earth circuit has feed introduction “imminent”; management is on track for terbium and dysprosium production later this year. Next print confirms/refutes: whether Dy/Tb was produced, what went into inventory (these costs exit the P&L until recognized through magnet sales), and whether first shipments reached Independence.
  4. Q3 pricing and PPA realization. Management guided realized NdPr oxide pricing to the high-$90s/kg with PPA income of ~$10/kg against ~$110/kg market pricing and a slight sequential PPA decline. Next print confirms/refutes both the price realization and the shape of the price-floor benefit as market prices move.
  5. Magnetics EBITDA path through the precursor roll-off. ~$46M of prepaid revenue is recognized over the next 3–4 quarters on a modestly declining basis while start-up costs (not yet inventoriable) press on the P&L. Next print confirms/refutes the guided “lumpy and nonlinear” bridge — watch Magnetics revenue/EBITDA and the remaining prepaid balance.

Secondary Tracking Items

  • Additional heavies offtakes: samarium (2028 first production) and yttrium commercialization; possible follow-on gadolinium volumes with the initial aerospace/defense customer.
  • Chlor-alkali operational benefits — early crystallizer improvements now; tangible cost benefits building progressively through 2027.
  • Reagent change implementation later this year (modestly higher direct cost; watch for flotation/water-quality benefits and any China-exposure commentary).
  • 10X construction pace: vertical construction began during the call; watch for enclosure/equipment milestones and any new customer announcements for capacity beyond DOW.
  • Project Swarm subscription conversion — whether drone-industry subscriptions convert into binding offtakes and whether the membership grows beyond “a number of participants.”
  • Channel inventory: ~650 mt of NdPr oxide/metal in the channel at June 30 — watch whether the drawdown continues or production growth forces a re-fill (a volume/timing variable for Materials revenue).
  • Exploratory drilling results at Mountain Pass (“more to come” on additional ore within pit contours) and the pre-flot scale implementation timeline (2028).
  • Any new China export-control developments affecting reagents/supply chain (management currently expects minimal impact).